BillionToOne Stock

billiontoone.comHealthcare / BioTech & PharmaFounded: 2016Funding to Date: $1.03B

BillionToOne is a molecular counter platform designed to accurately count DNA molecules to the single-count level. With a mission to detect disorders such as cystic fibrosis and sickle-cell disease, the company optimizes the signal-to-noise ratio through blood testing. The platform specializes in both prenatal and oncology divisions. BillionToOne was founded by David Tsao, Oguzhan Atay, and Sukrit Silas in 2016 and is headquartered in San Francisco, CA.

Register To Buy and Sell Private Company Shares

For more details on private stock price information, financing and valuation for BillionToOne, register or login.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

BillionToOne Stock Price

Forge Price 1
Price not yet available
Last Closed Trade 2
Close Date
xx/xx/xx
Last Closed Trade Price
$xx.xx
Last Funding Round (LFR)
Date
xx/xx/xx
Price per Share
$xx.xx

BillionToOne Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
06/21/2024 Series D $130.47MM $xx.xx $1.25B Adam Street Partners, Baillie Gifford, Civilization Ventures, Fifty Years, Hummingbird Ventures, Libertus Capital, Neuberger Berman, Premji Invest
Price per Share
$xx.xx
Shares Outstanding
4,656,233
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.2x
Conversion Ratio
1.2x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Adam Street Partners, Baillie Gifford, Civilization Ventures, Fifty Years, Hummingbird Ventures, Libertus Capital, Neuberger Berman, Premji Invest
12/15/2022 Series C-1 $33.87MM $xx.xx $813.63MM Adams Street Partners, Baillie Gifford, Fifty Years Vc, Hummingbird Ventures, Libertus Capital, Neotribe Ventures, Norwest Venture Partners, Time Bioventures
Price per Share
$xx.xx
Shares Outstanding
1,726,823
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Adams Street Partners, Baillie Gifford, Fifty Years Vc, Hummingbird Ventures, Libertus Capital, Neotribe Ventures, Norwest Venture Partners, Time Bioventures
03/30/2022 Series C $155MM $xx.xx $973.82MM Adams Street Partners, Baillie Gifford, Civilization Ventures, Fifty Years Vc, Hummingbird Ventures, Libertus Capital, Neotribe Ventures, Norwest Venture Partners, Pacific 8 Ventures, Time Bioventures
Price per Share
$xx.xx
Shares Outstanding
6,079,919
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Adams Street Partners, Baillie Gifford, Civilization Ventures, Fifty Years Vc, Hummingbird Ventures, Libertus Capital, Neotribe Ventures, Norwest Venture Partners, Pacific 8 Ventures, Time Bioventures
07/12/2021 Series B-1 $55MM $xx.xx $341.88MM Four Rivers Group, Hummingbird Ventures, Libertus Capital, Neotribe Ventures, Norwest Venture Partners, Y Combinator
Price per Share
$xx.xx
Shares Outstanding
5,182,287
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Four Rivers Group, Hummingbird Ventures, Libertus Capital, Neotribe Ventures, Norwest Venture Partners, Y Combinator
03/10/2020 Series B-2 $16.02MM $xx.xx $148.58MM 500 Startups, Civilization Ventures, Hof Capital, Hummingbird Ventures, Libertus Capital, Neotribe Ventures, Pacific 8 Ventures, Y Combinator
Price per Share
$xx.xx
Shares Outstanding
2,566,902
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
500 Startups, Civilization Ventures, Hof Capital, Hummingbird Ventures, Libertus Capital, Neotribe Ventures, Pacific 8 Ventures, Y Combinator
03/28/2019 Series A-6 $15.02MM $xx.xx $60.38MM 500 Startups, Civilization Ventures, Hof Capital, Hummingbird Ventures, Libertus Capital, Neotribe Ventures, Pacific 8 Ventures, Y Combinator
Price per Share
$xx.xx
Shares Outstanding
5,805,861
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
500 Startups, Civilization Ventures, Hof Capital, Hummingbird Ventures, Libertus Capital, Neotribe Ventures, Pacific 8 Ventures, Y Combinator
08/22/2017 Series A-1 $539,994.97 $xx.xx $45.29MM Friale, Newdo Venture, Pacific 8 Ventures, Uphonest Capital, Y Combinator
Price per Share
$xx.xx
Shares Outstanding
1,349,650
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Friale, Newdo Venture, Pacific 8 Ventures, Uphonest Capital, Y Combinator
08/22/2017 Series A-2 $909,995.44 $xx.xx $45.29MM Friale, Newdo Venture, Pacific 8 Ventures, Uphonest Capital, Y Combinator
Price per Share
$xx.xx
Shares Outstanding
1,137,210
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Friale, Newdo Venture, Pacific 8 Ventures, Uphonest Capital, Y Combinator
08/22/2017 Series A-5 $99,999.84 $xx.xx $45.29MM Friale, Newdo Venture, Pacific 8 Ventures, Uphonest Capital, Y Combinator
Price per Share
$xx.xx
Shares Outstanding
114,613
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Friale, Newdo Venture, Pacific 8 Ventures, Uphonest Capital, Y Combinator
08/22/2017 Series A-3 $899,999.92 $xx.xx $45.29MM Friale, Newdo Venture, Pacific 8 Ventures, Uphonest Capital, Y Combinator
Price per Share
$xx.xx
Shares Outstanding
899,730
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Friale, Newdo Venture, Pacific 8 Ventures, Uphonest Capital, Y Combinator
08/22/2017 Series A-4 $49,999.52 $xx.xx $45.29MM Friale, Newdo Venture, Pacific 8 Ventures, Uphonest Capital, Y Combinator
Price per Share
$xx.xx
Shares Outstanding
25,761
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Friale, Newdo Venture, Pacific 8 Ventures, Uphonest Capital, Y Combinator

BillionToOne Investors Also Invested in These Private Companies

Northwest Venture Partners
Time BioVentures
U.S. Department of Health and Human Services
Civilization Ventures
NewDo Venture
Brightway Future Capital
NYX Ventures Partners
Lombardstreet Ventures

Leadership & Board

Leadership

Oguzhan Atay Ph.D
Co-Founder & Chief Executive Officer
David Tsao Ph.D
Co-Founder & Chief Technology Officer
Thomas Lynch JD
General Counsel & Chief Compliance Officer
Shan Riku
Chief Product Officer
Ross Taylor
Chief Financial Officer
Gary Palmer JD
Chief Medical Officer

Board

Akshay Rai
Premji Invest
Casper de Clercq
Norwest Venture Partners
Firat Ileri
Hummingbird Ventures
Swaroop Kolluri
Neotribe Ventures
Thomas Bremner
Adams Street Partners

BillionToOne stock FAQs

plusminus

Can you buy BillionToOne stock?

As BillionToOne is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private companies like BillionToOne, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.
plusminus

How to buy BillionToOne stock?

To invest in a private company like BillionToOne through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell BillionToOne stock?

Yes, you may sell the BillionToOne stock you currently own. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company’s interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell BillionToOne stock?

If you hold private company shares of BillionToOne – whether as an employee or an early investor – Forge can help you sell them.

  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your BillionToOne on our platform.
  3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.
plusminus

Is BillionToOne a public company?

No, BillionToOne is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is BillionToOne’s stock price?

BillionToOne is a privately held company and therefore does not have a public stock price. However, you may access BillionToOne private market stock price with Forge Data.
plusminus

What is BillionToOne’s stock ticker symbol?

BillionToOne does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

BillionToOne News and Media Highlights

DNA testmaker BillionToOne claims billion-dollar valuation with $130M funding round

In a series D funding round led by Premji Invest, BillionToOne raised $130 million.

Leading Molecular Diagnostics Company BillionToOne Raises $130 Million in Oversubscribed Series D Funding Over $1B+ Valuation

BillionToOne, a next-generation molecular diagnostics company, announced today that it has raised $130 million in an oversubscribed, upsized Series D round. The financing was led by Premji Invest, with significant participation by another incoming investor, Neuberger Berman, as well as by prominent existing investors, including Adam Street Partners, Baillie Gifford, Hummingbird Ventures, Civilization Ventures, Libertus Capital, and Fifty Years. The funding will be used for expanding and scaling BillionToOne’s prenatal and oncology businesses.

BillionToOne Scores $48.5 Million - Silicon Valley Daily

BillionToOne, Inc., a molecular diagnostics company, has secured an additional $48.5 million of funding from existing equity investors as well as upsized its Term Loan Facility with access to up to $35 million, with its existing lender, Bridge Bank.
Browse Insights
Updated on: Dec 17, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge.  Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.